论文部分内容阅读
目的探讨实施品管圈活动对头颈部肿瘤患者放疗后放射性皮炎的干预效果,探索有效的解决途径。方法以入院病例号为编号,根据随机数字表,将2013年10月—2015年10月入科治疗的160例头颈部肿瘤放疗患者随机分成2组,每组80例。对照组放疗后按照常规护理方法护理;观察组患者放疗后按照品管圈活动进行护理。比较护理后患者放射性皮炎的发生情况。采用SPSS 17.0统计软件进行统计分析,P<0.05为差异有统计学意义。结果观察组0度皮炎人数为34例(42.5%),高于对照组的22例(27.5%);中断放疗的人数为4例(5.0%),低于对照组的13例(16.3%),差异有统计学意义(P<0.05);放射性皮肤反应的时间为(10.4±2.3)d,显著长于对照组的(6.5±1.5)d,差异有统计学意义(P<0.05);观察组患者满意度为97.5%(78/80),显著高于对照组的80.0%(64/80),差异有统计学意义(P<0.05)。结论实施品管圈活动进行头颈部肿瘤放疗患者护理可有效降低放射性皮炎的发生几率,改善患者放疗后生活质量。
Objective To explore the effect of quality control ring intervention on radiodermatitis after radiotherapy in patients with head and neck cancer and explore effective ways to solve it. Methods According to the random number table, 160 patients with head and neck cancer treated by radiotherapy from October 2013 to October 2015 were randomly divided into two groups (n = 80 in each group). Patients in the control group were treated according to the routine nursing method after radiotherapy. Patients in the observation group were treated according to the quality control circle after radiotherapy. Compare the incidence of radiodermatitis patients after care. SPSS 17.0 statistical software for statistical analysis, P <0.05 for the difference was statistically significant. Results The number of 0 dermatitis patients in observation group was 34 cases (42.5%), which was higher than that in control group (22 cases) (27.5%). The number of patients who received radiotherapy was 4 cases (5.0% , The difference was statistically significant (P <0.05); the time of radioactive skin reaction was (10.4 ± 2.3) d, significantly longer than that of the control group (6.5 ± 1.5) d, the difference was statistically significant (P <0.05) Patient satisfaction was 97.5% (78/80), significantly higher than that of the control group (80.0%, 64/80). The difference was statistically significant (P <0.05). Conclusion The implementation of quality control activities for patients with head and neck cancer radiotherapy can effectively reduce the incidence of radiation dermatitis and improve the quality of life of patients after radiotherapy.